Julia A. Guzova

849 total citations
11 papers, 596 citations indexed

About

Julia A. Guzova is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Julia A. Guzova has authored 11 papers receiving a total of 596 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Immunology and 6 papers in Cancer Research. Recurrent topics in Julia A. Guzova's work include NF-κB Signaling Pathways (6 papers), Immune Response and Inflammation (4 papers) and Cytokine Signaling Pathways and Interactions (3 papers). Julia A. Guzova is often cited by papers focused on NF-κB Signaling Pathways (6 papers), Immune Response and Inflammation (4 papers) and Cytokine Signaling Pathways and Interactions (3 papers). Julia A. Guzova collaborates with scholars based in United States, Taiwan and Germany. Julia A. Guzova's co-authors include Sheri L. Bonar, Sumathy Mathialagan, Nandini Kishore, Catherine S. Tripp, Min Yao, Richard M. Weier, Thao Perry, Lee D. Albee, Matthew J. Graneto and Scott D. Hauser and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Julia A. Guzova

11 papers receiving 591 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julia A. Guzova United States 9 331 225 221 105 39 11 596
Gao Liu China 14 470 1.4× 388 1.7× 156 0.7× 133 1.3× 24 0.6× 35 833
Nicole Bacher Austria 11 202 0.6× 96 0.4× 183 0.8× 127 1.2× 37 0.9× 14 510
Weigan Shen China 14 299 0.9× 139 0.6× 142 0.6× 78 0.7× 54 1.4× 44 595
Kevin P. Mouillesseaux United States 13 424 1.3× 91 0.4× 208 0.9× 94 0.9× 19 0.5× 17 751
Junichi Hisatake Japan 11 424 1.3× 149 0.7× 98 0.4× 119 1.1× 24 0.6× 21 784
Ming Lv China 17 369 1.1× 125 0.6× 107 0.5× 116 1.1× 21 0.5× 46 691
Ellen Herlaar United Kingdom 6 324 1.0× 70 0.3× 228 1.0× 104 1.0× 45 1.2× 8 699
Huaxin Zhou China 16 397 1.2× 151 0.7× 166 0.8× 150 1.4× 20 0.5× 42 756
Hae Jong Kim South Korea 15 318 1.0× 89 0.4× 92 0.4× 123 1.2× 30 0.8× 32 625
Dongsheng Ping United States 9 335 1.0× 256 1.1× 480 2.2× 264 2.5× 25 0.6× 9 846

Countries citing papers authored by Julia A. Guzova

Since Specialization
Citations

This map shows the geographic impact of Julia A. Guzova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia A. Guzova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia A. Guzova more than expected).

Fields of papers citing papers by Julia A. Guzova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia A. Guzova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia A. Guzova. The network helps show where Julia A. Guzova may publish in the future.

Co-authorship network of co-authors of Julia A. Guzova

This figure shows the co-authorship network connecting the top 25 collaborators of Julia A. Guzova. A scholar is included among the top collaborators of Julia A. Guzova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia A. Guzova. Julia A. Guzova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Guzova, Julia A., Michael J. Primiano, Aiping Jiao, et al.. (2019). Optimized protocols for studying the NLRP3 inflammasome and assessment of potential targets of CP-453,773 in undifferentiated THP1 cells. Journal of Immunological Methods. 467. 19–28. 10 indexed citations
2.
Primiano, Michael J., Bruce A. Lefker, Michael Bowman, et al.. (2016). Efficacy and Pharmacology of the NLRP3 Inflammasome Inhibitor CP-456,773 (CRID3) in Murine Models of Dermal and Pulmonary Inflammation. The Journal of Immunology. 197(6). 2421–2433. 143 indexed citations
3.
Guzova, Julia A., Sumathy Mathialagan, Medora M. Hardy, et al.. (2010). Novel Insights into the Cellular Mechanisms of the Anti-inflammatory Effects of NF-κB Essential Modulator Binding Domain Peptides. Journal of Biological Chemistry. 285(18). 13498–13506. 38 indexed citations
4.
Bonafoux, D., Sheri L. Bonar, Michael Clare, et al.. (2009). Aminopyridinecarboxamide-based inhibitors: Structure–activity relationship. Bioorganic & Medicinal Chemistry. 18(1). 403–414. 6 indexed citations
5.
Mbalaviele, Gabriel, Cynthia D. Sommers, Sheri L. Bonar, et al.. (2009). A Novel, Highly Selective, Tight Binding IκB Kinase-2 (IKK-2) Inhibitor: A Tool to Correlate IKK-2 Activity to the Fate and Functions of the Components of the Nuclear Factor-κB Pathway in Arthritis-Relevant Cells and Animal Models. Journal of Pharmacology and Experimental Therapeutics. 329(1). 14–25. 56 indexed citations
6.
Chiang, Po‐Chang, Yiding Hu, Archie Thurston, et al.. (2009). Pharmacokinetic and Pharmacodynamic Evaluation of the Suitability of Using Fluticasone and an Acute Rat Lung Inflammation Model to Differentiate Lung Versus Systemic Efficacy. Journal of Pharmaceutical Sciences. 98(11). 4354–4364. 11 indexed citations
7.
Sommers, Cynthia D., Janice Thompson, Julia A. Guzova, et al.. (2009). Novel Tight-Binding Inhibitory Factor-κB Kinase (IKK-2) Inhibitors Demonstrate Target-Specific Anti-Inflammatory Activities in Cellular Assays and following Oral and Local Delivery in an in Vivo Model of Airway Inflammation. Journal of Pharmacology and Experimental Therapeutics. 330(2). 377–388. 28 indexed citations
8.
Bonafoux, D., Sheri L. Bonar, Michael Clare, et al.. (2005). Inhibition of IKK-2 by 2-[(aminocarbonyl)amino]-5-acetylenyl-3-thiophenecarboxamides. Bioorganic & Medicinal Chemistry Letters. 15(11). 2870–2875. 24 indexed citations
9.
Kishore, Nandini, Sumathy Mathialagan, Julia A. Guzova, et al.. (2003). A Selective IKK-2 Inhibitor Blocks NF-κB-dependent Gene Expression in Interleukin-1β-stimulated Synovial Fibroblasts. Journal of Biological Chemistry. 278(35). 32861–32871. 247 indexed citations
10.
Hsu, Li‐Chung, Nai-Chi Hsu, Julia A. Guzova, et al.. (1996). The Common I172N Mutation Causes Conformational Change of Cytochrome P450c21 Revealed by Systematic Mutation, Kinetic, and Structural Studies. Journal of Biological Chemistry. 271(6). 3306–3310. 32 indexed citations
11.
Guzov, Victor M., et al.. (1996). Expression of functionally active human cytochrome P-450c21 (CYPXXIA2) in Escherichia coli and one-step purification of the recombinant protein by metal chelate affinity chromatography. 61(10). 1242–1252. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026